Data derived from the three online databases showed that rs1784042 correlates with the expression of SIDT2 and TAGLN. We assume that the SNPs associated with MetS could activate the expression of the genes SIDT2 and TAGLN. A change in gene expression might inhibit insulin secretion, lipid metabolism and adipogenesis, resulting in MetS. The gene discussed is SIDT2; the disease is metabolic syndrome.